Welcome to our dedicated page for Pheton Holdings SEC filings (Ticker: PTHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Pheton Holdings Ltd (PTHL), a Cayman Islands healthcare solution provider focused on treatment planning systems for brachytherapy and related products and services. As a foreign private issuer, the company files an annual report on Form 20-F and furnishes current reports on Form 6-K to disclose financial information and material corporate events.
Through Pheton’s SEC filings, readers can review unaudited interim condensed consolidated financial statements, which have been furnished on Form 6-K for specified periods. These filings include financial statements and accompanying notes, as well as Inline XBRL data files that structure key financial information for analysis.
The company’s 6-K reports also document corporate governance and organizational changes, such as the appointment and resignation of independent directors, the engagement of an independent registered public accounting firm, and the furnishing of notices and proxy statements for its annual general meeting of shareholders. Certain filings include updated memorandum and articles of association, reflecting changes associated with the corporate name iTonic Holdings Ltd.
Investors can find details on capital markets and transaction activity in Pheton’s filings. The company has reported its initial public offering on the Nasdaq Capital Market, advisory services agreements related to mergers and acquisitions strategies, and stock purchase agreements to acquire equity interests in healthcare technology targets, including iTonic Corporation and a company established to develop and commercialize advanced medical device technologies. These reports describe consideration structures involving newly issued Class A ordinary shares and warrants, as well as regulatory exemptions relied upon for unregistered sales of securities.
Filings further disclose Nasdaq listing compliance matters, including a notice from the Nasdaq Listing Qualifications Department regarding non-compliance with the minimum bid price requirement and the associated compliance period. In addition, a current report describes Pheton’s plan to change its corporate name to iTonic Holdings Ltd and its Nasdaq ticker symbol from "PTHL" to "ITOC," explaining that these changes reflect a new business strategy and future development plans.
On Stock Titan, these SEC documents are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy filings such as Form 20-F annual reports or detailed Form 6-K exhibits. Users can quickly identify key points about Pheton’s financial condition, acquisitions, governance changes, and listing status, and can also review disclosures related to equity issuances and warrant arrangements. For those researching the historical PTHL ticker and the transition to ITOC, this filings archive offers a structured view of how the company’s regulatory record has developed over time.
iTonic Holdings Ltd director and CEO Zhang Jianfei has filed an initial statement of ownership. The filing shows direct ownership of 33,346 Class A Ordinary Shares. It also reports indirect ownership of 7,668,000 Class B Ordinary Shares held through ZJW (BVI) LTD, where Zhang is the sole shareholder and director. No new purchases or sales are reported; this document mainly establishes Zhang’s status as a major shareholder and executive of iTonic Holdings.
iTonic Holdings Ltd filed an amended Form 20-F mainly to correct the date on Marcum Asia CPAs LLP’s audit report; no other disclosures were changed, although new CEO and CFO certifications were included.
For 2025, iTonic reported revenue of $523,031 and a net loss of $5,098,384, driven by sharp increases in general and administrative and research and development expenses. The auditor and management highlight substantial doubt about the company’s ability to continue as a going concern, noting operating losses, negative operating cash flow of $3,231,427 and the need for additional equity or debt financing to fund operations.
Total assets were $9,096,296 at year-end 2025, including newly recognized goodwill of $1,955,683 and customer-relationship intangibles of $2,414,357 from acquisitions. Cash and cash equivalents fell to $1,490,129 from $6,159,823 as the company invested in short-term investments, acquisitions and operations. Class A ordinary shares outstanding increased to 9,382,000, partly reflecting a 2,800,000-share-based payment in 2025 on top of the 2024 IPO of 2,250,000 Class A shares.
iTonic Holdings Ltd, a Cayman Islands company with operating subsidiary Beijing Feitian, files its annual Form 20-F covering the year ended December 31, 2025. The business focuses on brachytherapy treatment planning software and related medical auxiliary supplies for cancer care in China.
All revenue and operations are in the PRC, so results depend heavily on China’s economic conditions, healthcare policies and medical device regulations. The report emphasizes reliance on multiple PRC licenses and production/operation permits, foreign-exchange and dividend remittance controls, evolving cybersecurity and data rules, and potential PRC tax-residency and withholding tax exposure. It also highlights rising labor and social-benefit costs, stricter employment compliance, and uncertainties around foreign investment, M&A and overseas listings rules that could affect future financing and expansion.
iTonic Holdings Ltd has agreed to a March 2026 private placement of 100,000,000 Class A ordinary shares at US$0.20 per share, for aggregate gross proceeds of about US$20,000,000 to the company. The transaction is expected to close in April 2026, subject to the conditions in the subscription agreement.
The new shares will be subject to a six-month lock-up period from issuance, limiting immediate resale. This report is also incorporated by reference into iTonic’s existing Form S-8 and effective Form F-3 registration statements.
iTonic Holdings Ltd director Zhang Pengfei filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing does not report any stock purchases, sales, option exercises, or other transactions; it simply establishes Zhang’s status as a reporting director at iTonic Holdings.
iTonic Holdings Ltd executive Li Zhixin, the company’s CFO, has filed an initial Form 3 as an officer of the company. The provided data does not show any insider transactions or derivative positions, indicating this filing functions mainly as a baseline ownership disclosure.
Pheton Holdings Ltd is furnishing unaudited interim condensed consolidated financial statements for the six months ended June 30, 2025, in a report as a foreign private issuer. These statements, attached as Exhibit 99.1, cover the six-month periods ended June 30, 2024 and 2025 and provide a detailed view of the company’s mid-year financial position and operating results.
Pheton Holdings Ltd has appointed Fortune CPA, Inc. as its independent registered public accounting firm under an engagement letter dated December 8, 2025. The appointment was approved by the company’s audit committee of the board of directors, confirming board-level authorization of Fortune CPA’s role as the external auditor for the company.
Pheton Holdings Ltd (PTHL) submitted a Form 6-K related to its 2025 Annual General Meeting of Shareholders. The filing primarily serves to furnish key shareholder materials for that meeting.
The submission includes the notice and proxy statement for the annual meeting, as well as the Third Amended and Restated Memorandum of Association and Third Amended and Restated Articles of Association of iTonic Holdings Ltd. The report is signed by Chief Executive Officer and Chairman Jianfei Zhang on behalf of the company.